[Locally-advanced cervix cancer : multidisciplinary management]

Area of Science:

• Oncology
• Gynecologic Oncology
• Radiation Oncology

Background:

• Cervical cancer is a major global health concern for women, often diagnosed at advanced stages.
• Human papillomavirus (HPV) infection is implicated in over 95% of cervical cancer cases.
• Despite advances, locally advanced cervical cancer presents significant survival and treatment challenges.

Purpose of the Study:

• To review the evolving management strategies for locally advanced cervical cancer.
• To highlight the impact of imaging technologies on treatment outcomes.
• To discuss current standard treatments and emerging therapeutic approaches.

Main Methods:

• Review of current treatment protocols for locally advanced cervical cancer.
• Analysis of the role of imaging in treatment planning and delivery.
• Evaluation of standard chemoradiation and brachytherapy techniques.
• Assessment of ongoing research into neoadjuvant, adjuvant, and novel therapies like immunotherapy.

Main Results:

• Significant improvements in survival and local control for locally advanced cervical cancer have been achieved.
• Implementation of advanced imaging has led to reduced treatment toxicity.
• Standard treatment involves concurrent chemoradiation followed by brachytherapy.
• The efficacy of neoadjuvant/adjuvant chemotherapy and immunotherapy is under active investigation.

Conclusions:

• Modern management strategies, integrating imaging and standard therapies, have improved outcomes for locally advanced cervical cancer.
• Ongoing research into novel agents like immunotherapy holds promise for further enhancing treatment efficacy.
• Continued evaluation of chemotherapy and innovative treatments is crucial for advancing cervical cancer care.